Gregory W. Ruhnke to Cohort Studies
This is a "connection" page, showing publications Gregory W. Ruhnke has written about Cohort Studies.
Connection Strength
0.137
-
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study. Br J Cancer. 2015 Jun 30; 113(1):57-63.
Score: 0.041
-
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. J Clin Oncol. 2014 Apr 20; 32(12):1228-35.
Score: 0.038
-
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients. Clin Pharmacol Ther. 2014 Jun; 95(6):644-52.
Score: 0.037
-
Preventability and Causes of Readmissions in a National Cohort of General Medicine Patients. JAMA Intern Med. 2016 Apr; 176(4):484-93.
Score: 0.022